muramylnac-ala-isogln-lys-tripeptide and Plasmacytoma

muramylnac-ala-isogln-lys-tripeptide has been researched along with Plasmacytoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujiwara, H; Hamaoka, T; Kosugi, A; Kusama, T; Ogata, M; Sano, H; Shima, J	1

Other Studies

1 other study(ies) available for muramylnac-ala-isogln-lys-tripeptide and Plasmacytoma

Article	Year
Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity. Infection and immunity, 1986, Volume: 54, Issue:3 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Cell Membrane; Cross Reactions; Female; Haptens; Lymph Nodes; Lymphocyte Activation; Mice; Mycobacterium; Neutralization Tests; Plasmacytoma; Structure-Activity Relationship; T-Lymphocytes	1986

Article

Year

Cross-reactivity between haptenic muramyl di- or tripeptide derivatives and Mycobacterium bovis BCG: potential application for enhancing tumor immunity.

Infection and immunity, 1986, Volume: 54, Issue:3

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Cell Membrane; Cross Reactions; Female; Haptens; Lymph Nodes; Lymphocyte Activation; Mice; Mycobacterium; Neutralization Tests; Plasmacytoma; Structure-Activity Relationship; T-Lymphocytes

1986